Pharmaco - Press Releases

Date	Title	Company
10-Mar-2022	Grifols’ XEMBIFY® receives European approvals, expanding access to innovative therapies	Grifols
10-Mar-2022	PharmaLex expands pricing & reimbursement and health economics platform with EBMA Consulting merger	PharmaLex
10-Mar-2022	Bayer receives MHRA authorisation in Great Britain for Kerendia® (finerenone) as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes	Bayer
10-Mar-2022	Cherwell highlights how SAS Daily Heads can help reduce risk in Environmental Monitoring	Cherwell Laboratories
10-Mar-2022	HCS Pharma expects 90% success rate on Cancer drugs tests due to recreation of organs in-vitro with BIOMIMESYS® technology	HCS Pharma
10-Mar-2022	Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting	Nordic Nanovector
10-Mar-2022	Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment	Sanofi
10-Mar-2022	Thermo Fisher Scientific Unveils New Genetic Analyzer to Bring Advanced Capabilities to Sanger Sequencing and Fragment Analysis	Thermo Fisher Scientific
10-Mar-2022	Neuraxpharm expands its business in Southeast Europe	Neuraxpharm
10-Mar-2022	NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer	Sciad Newswire
10-Mar-2022	Abivax reports promising ABX464 phase 2a one-year maintenance results in rheumatoid arthritis	ABIVAX
10-Mar-2022	Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117	Heidelberg Pharma AG
10-Mar-2022	Evolva grew product-related revenue by 40% in 2021	Evolva Holding SA
10-Mar-2022	Biotest AG: Biotest AG opens ninth plasma collection centre in Czech Republic	Biotest AG
09-Mar-2022	BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG	BRAIN Biotech AG
09-Mar-2022	Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful	CSL Behring AG
09-Mar-2022	MODERNA ANNOUNCES MEMORANDUM OF UNDERSTANDING WITH THE GOVERNMENT OF THE REPUBLIC OF KENYA TO ESTABLISH ITS FIRST MRNA MANUFACTURING FACILITY IN AFRICA	MODERNA
09-Mar-2022	Asgard Therapeutics reaches a major research milestone in the development of a new type of cancer treatment	Asgard Therapeutics
09-Mar-2022	Oxford Medical Products raises £2.5 million for its hydrogel weight-loss platform technology	Sciad Newswire
09-Mar-2022	Spexis to present strategy update and full-year 2021 financial results on March 24, 2022	Spexis AG